Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chang Li Nano Biotechnology is a Taiwan-based company specializing in the application of nanotechnology to the life sciences and healthcare sectors. Founded in 2005 and headquartered in the Southern Taiwan Science Park, the company focuses on the development and manufacturing of nano-gold and nano-silver materials for use in health supplements, skincare, and medical applications. Their core expertise lies in high-purity nanoparticle production and advanced herbal extraction technologies, particularly for functional ingredients like Antrodia cinnamomea. The company operates GMP-certified facilities and provides comprehensive OEM/ODM services for global clients in the functional food and cosmetic industries. By leveraging its proprietary nano-delivery platforms, Chang Li Nano aims to enhance the bioavailability and efficacy of bioactive compounds. Their product portfolio includes a wide range of cosmeceuticals and nutraceuticals marketed under various brands and partner labels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 長利奈米生物科技.